Journal of the American College of Cardiology Vol. 47, No. 7, by the American College of Cardiology Foundation ISSN /06/$32.

Transcription

1 Journal of the American College of Cardiology Vol. 47, No. 7, by the American College of Cardiology Foundation ISSN /06/$32.00 Published by Elsevier Inc. doi: /j.jacc Independent Factors Associated With Mortality, Reintervention, and Achievement of Complete Repair in Children With Pulmonary Atresia With Ventricular Septal Defect Congenital Heart Disease Kerstin M. Amark, MD,* Tara Karamlou, MD, Aoife O Carroll, MS, Cathy MacDonald, MD, Robert M. Freedom, MD, Shi-Joon Yoo, MD, William G. Williams, MD, Glen S. Van Arsdell, MD, Christopher A. Caldarone, MD, Brian W. McCrindle, MD, MPH Göteborg, Sweden; and Toronto, Canada OBJECTIVES BACKGROUND METHODS RESULTS CONCLUSIONS We described morphologic characteristics, particularly pulmonary anatomy, and determined the prevalence of definitive end states and their determinants in children with pulmonary atresia associated with ventricular septal defect (PAVSD). Pulmonary atresia associated with ventricular septal defect represents a broad morphologic spectrum that greatly influences management and outcomes. From 1975 to 2004, 220 children with PAVSD presented to our institution. Blinded angiographic review (n 171) characterized bronchopulmonary segment arterial supply. A total of 185 patients underwent surgery, and repair was definitive in 75%. Initial operations included systemic-pulmonary artery shunt in 57%, complete primary repair in 31%, or right ventricular outflow tract reconstruction in 12%. Based on angiographic review, 118 patients had simple PAVSD and 53 patients had PAVSD with major aortopulmonary collateral arteries (MAPCAs). Overall survival from initial operation was 71% at 10 years. Risk factors for death after initial operation included younger age at repair, earlier birth cohort, fewer bronchopulmonary segments supplied by native pulmonary arteries, and initial placement of a systemic-pulmonary artery shunt. Competing-risks analysis for initially palliated patients predicted that after 10 years, 68% achieved complete repair (with associated factors including later birth cohort and more bronchopulmonary segments supplied by native pulmonary arteries), 22% died without repair, and 10% remained alive without repair. Reoperations after complete repair occurred in 38 children (27%), with risk factors including older age at palliation, MAPCAs, and more segments supplied by collaterals. Outcomes in children with PAVSD have improved over time, and are better in completely repaired cases. Bronchopulmonary arterial supply is an important determinant of mortality, achievement of definitive repair, and post-repair reoperation. (J Am Coll Cardiol 2006;47: ) 2006 by the American College of Cardiology Foundation The complexity of bronchopulmonary anatomy complicates management of patients with pulmonary atresia and ventricular septal defect (PAVSD) (1 5). Early primary repair has been applied in patients with simple PAVSD (welldeveloped central pulmonary arteries supplied by a ductus arteriosus), analogous to the treatment paradigm for tetralogy of Fallot (6). Several groups have similarly advocated single-stage complete unifocalization in patients with major aortopulmonary collateral arteries (MAPCAs) (7,8), but important interim attrition and morbidity with this approach mandates further evaluation. Management of patients with PAVSD and MAPCAs has evolved at the Hospital for Sick Children from a multi-staged approach to From the *Department of Pediatric Cardiology, Göteborg University, The Queen Silvia Children s Hospital, Göteborg, Sweden; and the Division of Cardiovascular Surgery, Department of Surgery, Division of Cardiology, Department of Pediatrics, and the Division of Diagnostic Imaging, Department of Radiology, University of Toronto, The Hospital for Sick Children, Toronto, Ontario, Canada. Manuscript received June 1, 2005; revised manuscript received October 4, 2005, accepted October 10, one emphasizing complete single-stage unifocalization in patients with adequate central pulmonary arterial size. We sought to describe morphologic characteristics, with special attention to pulmonary anatomy, and to determine the prevalence of definitive end states and their determinants in children with PAVSD. We also sought to characterize outcomes over time and to establish whether trends could be correlated with the predominant management strategy operational in that era. METHODS Patients. After approval by the Research Ethics Board at the Hospital for Sick Children, 220 children 18 years of age with unrepaired PAVSD referred from 1975 to 2004 were identified by the cardiology database and their medical records were reviewed (Table 1). Data were collected from admission, before any intervention, and at the last available follow-up. Patients or caregivers were contacted by telephone in cases in which current follow-up data were

2 JACC Vol. 47, No. 7, 2006 April 4, 2006: Amark et al. Pulmonary Atresia with VSD 1449 Abbreviations and Acronyms MAPCA major aortopulmonary collateral arteries PAVSD pulmonary atresia associated with ventricular septal defect RVOT right ventricular outflow tract unavailable. Median follow-up time was 3.8 years (ranging to 26 years) from first admission, and is 98% complete for survivors. Pulmonary arterial anatomy. Pulmonary arterial anatomy was documented by single-observer blinded review of the initial (n 171) and follow-up (n 98) angiograms (Table 1). Echocardiographic data were used for determination of intracardiac anatomy in patients without cardiac catheterization (n 49). Central pulmonary arteries were located angiographically by relation to main bronchi, or by the seagull sign (9). Pulmonary arteries and the aorta were measured in the same angiogram or cardiac cycle phase. Non-dichotomous unpredictable peripheral branching was considered abnormal, as were dilated and tortuous pulmonary arteries. Stenoses were graded as present or absent. Direct collaterals were defined as native vessels arising from the aorta, and indirect collaterals were defined as originating from major aortic branches (10). Based on initial angiographic findings, the supply to the 18 bronchopulmonary segments was defined using the following definitions: 1) isolated segments had no connection to the central pulmonary arteries; 2) dual supplied segments were supplied by native pulmonary arteries via the ductus arteriosus and collaterals; 3) unperfused segments had no arterial supply; and 4) abnormal segments were defined qualitatively as those with an abnormal peripheral branching pattern. Patients with fully characterized pulmonary arterial anatomy (n 171) were then classified into two groups based on whether the majority of the bronchopulmonary segments were supplied by collaterals, the MAPCA group (n 53), or by native pulmonary arteries through the ductus arteriosus, the non-mapca group (n 118). In follow-up angiograms, hemodynamic measurements were recorded, and right ventricular dilation, right and left ventricular function, and pulmonary regurgitation were qualitatively described (Table 2). Data analysis. Data are presented as frequency, median with range, or mean SD as appropriate, with the number of missing values indicated. Percentages, hazard functions, and competing risk estimates are presented with confidence limits equivalent to 1 standard error (68%). All data analyses were performed using SAS statistical software (version 9, SAS Institute, Cary, North Carolina). Categorical and continuous non-timed event outcomes were evaluated with multivariable logistic and linear regression analyses. Multiphase parametric modeling of the hazard function (11) and competing risks methodology (12,13) were used to determine rates of transition to mutually exclusive time-related Table 1. Initial Patient Characteristics (n 220) Variable Value Missing Demographic characteristics Admission age (yrs) 0 (0 10.6) 0 Gender (female/male) 114:106 0 Noncardiac anomaly 73 (34%) 4 Chromosomal anomaly 50 (23%) 0 Morphologic characteristics Type of pulmonary atresia Muscular 94 (52%) 38 Valvular 58 (32%) 38 Segment gap 30 (16%) 38 VSD type Perimembranous 180 (85%) 7 Muscular 18 (8%) 7 Restrictive 4 (2%) 7 Multiple 11 (5%) 7 Right aortic arch 66 (30%) 3 Aberrant subclavian artery 30 (14%) 13 Patent ductus arteriosus 115 (63%) 37 Coronary artery abnormality* 31 (19%) 54 Left superior vena cava 14 (7%) 6 Aortic valve stenosis 9 (4%) 6 Aortic valve regurgitation 15 (8%) 20 Mitral valve abnormality 4 (2%) 6 Pulmonary arterial anatomy LPA absent 15 (7%) 1 RPA absent 19 (9%) 1 Absent main pulmonary artery segment 22 (11%) 15 Non-confluent pulmonary arteries 30 (14%) 1 LPA branch stenosis 66 (37%) 41 RPA branch stenosis 32 (18%) 45 LPA proximal (cm) LPA distal (cm) RPA proximal (cm) RPA distal (cm) McGoon ratio Nakata index (mm 2 m 2 ) Values are median (range), n (%), or mean SD. *Includes LAD artery from RCA in 5, accessory LAD in 7, single left coronary artery in 9, single RCA in 2, coronary artery to pulmonary artery fistula in 5, and coronary-cameral fistula in 1. Includes left superior vena cava to coronary sinus in 13 and left superior vena cava to left atrium in 1. Includes parachute mitral valve in 3 and mild dysplasia in 1. Measured before first branch point. LAD left anterior descending; LPA left pulmonary artery; RCA right coronary artery; RPA right pulmonary artery; VSD ventriculoseptal defect. events. Multiphase parametric modeling (14) is a totally parametric (as opposed to the semi-parametric method established by Cox [15]) method of analysis that accommodates both the time-related freedom from an event and also the time-varying nature of risk (phases of risk) for that event. Hazard function analysis that incorporates these phases is ideal for understanding many postoperative events, including those in the present study, in which the early risk of an event such as death (i.e., hazard) after surgery is initially high, rapidly declines to a more constant non-zero hazard, followed by a later increase in risk thereafter. The graphic depiction of overall survival generated from modeling the hazard function (which in this case has two phases) contains solid lines, which are continuous point estimates enclosed by 70% confidence limits. Model building begins by nonparametric (Kaplan-Meier) estimation, which reveals the shape of risk over the period of

3 1450 Amark et al. JACC Vol. 47, No. 7, 2006 Pulmonary Atresia with VSD April 4, 2006: Table 2. Patient Characteristics at Follow-Up Variable Value Missing Clinical follow-up (n 216) Interval from admission (yrs) 3.8 (0 26) 0 Saturation (%) Below 25% for weight 59 (44%) 81 Angiographic characteristics (n 98) Interval from admission 6.7 (0 18) 0 (yrs, median, range) Pulmonary arterial anatomy Number of residual collaterals LPA main branch stenosis 41 (46%) 9 RPA main branch stenosis 33 (37%) 9 Multilevel stenoses* 17 (19%) 9 Bilateral PA stenosis 17 (19%) 9 LPA proximal (cm) LPA distal (cm) RPA proximal (cm) RPA distal (cm) McGoon ratio Nakata index (mm 2 m 2 ) McGoon ratio 0.6 ( ) 44 Nakata index 102 ( ) 33 Intracardiac anatomy Reduced LV function 2 (2%) 17 Reduced RV function 19 (26%) 25 RV dilation 52 (75%) 28 Pulmonary regurgitation 59 (81%) 25 Hemodynamic measurements PA systolic pressure (mm Hg) RV pressure/systemic pressure (%) Clinical status (n 126) Asymptomatic without limitations 73 (58%) Asymptomatic except palpitations 1 (1%) Asymptomatic except chest pain 1 (1%) Mild exercise intolerance/dyspnea 14 (11%) Severe exercise intolerance 24 (19%) Feeding difficulties/poor weight gain 3 (2%) Learning disability/developmental delay 8 (6%) Other 2 (2%) The present study considers that patients make a transition from an initial state (called event-free survival after palliation) to two other states (complete repair and death without complete repair) that are considered to be terminating. All palliated patients in this example begin alive at time zero, and thereafter migrate (or transition) to the two specified end states at a rate determined by the underlying hazard function. Rates of transition, or rates of migration, from the initial state to one of the events (called an end state) are individual, independent hazard functions. Incremental risk factors associated with each state were identified by multivariable regression analysis as previously described (16). Mathematical transformations of continuous variables, such as logarithms, polynomials, and square or inverse functions, were used to optimize calibration of the variable to the risk of outcome events, and interactions among retained variables in the model were considered in all multivariable analyses. Variable selection was guided by bootstrap validation (16). RESULTS Initial morphologic characteristics. Bronchopulmonary anatomy is characterized by a continuous morphologic spectrum, but as confirmation of our definition, MAPCA patients are polarized at either end of this spectrum (Fig. 1). Compared with those in the non-mapca group (n 118), the 53 MAPCA patients had a smaller McGoon ratio ( vs ), fewer bronchopulmonary segments supplied by the true pulmonary arteries ( vs ), and more segments with a dual supply (9.0 Values are median (range), mean SD, or n (%). *Includes those with main branch and lobar branch stenosis. Measured before the first branch point. Calculated as (value at follow-up initial value). LV left ventricle; PA pulmonary artery; RV right ventricle; other abbreviations as in Table 1. follow-up (i.e., is there early attrition followed by a gradual increase, or is there only ongoing constant risk?) Hazard models are then constructed using the loglikelihood method, and model fit is also examined graphically by comparing the parametric estimates to the nonparametric estimates (shown in the graph as superimposed circles with error bars). Competing risks analysis is a method of time-related data analysis in which multiple, mutually exclusive events are considered simultaneously. Competing risks analysis is integrative in that it considers multiple outcomes in the context of one another, and can therefore address the question of how often an event may occur in the presence of other events for which a patient is at simultaneous risk. A familiar example of this phenomenon is the estimated prevalence of prosthetic valve replacement adjusted for the estimated prevalence of death occurring before replacement. Figure 1. Bronchopulmonary arterial anatomy in pulmonary atresia associated with ventricular septal defect (PAVSD) is characterized by a continuous morphologic spectrum, but our definition of major aortopulmonary collateral arteries (MAPCA) patients is supported by the obvious polarization of those in the non-mapca group (closed circles) and those in the MAPCA group (open circles). There is a strong negative correlation (r 2 0.8; p 0.001) between increasing number of bronchopulmonary segments supplied by the native pulmonary arteries and decreasing number of bronchopulmonary segments with abnormal supply. Abnormal supply number of dual supplied segments number of unperfused segments number of collateral supplied segments; PA pulmonary artery; RVOT right ventricular outflow tract.

4 JACC Vol. 47, No. 7, 2006 April 4, 2006: Amark et al. Pulmonary Atresia with VSD 1451 Figure 2. Overview of events in all patients admitted with a diagnosis of pulmonary atresia associated with ventricular septal defect (PAVSD). RVOT right ventricular outflow tract. 0.9 vs ) or that were unperfused ( vs ) (p for all). Initial surgical procedures. OVERALL. Of the initial 220 patients, operative intervention was undertaken at first admission in 187 at a median age of 18 days (range, 0 to 10.6 years), 2 of whom had exploration only without any reparative procedure (Fig. 2). Systemic-pulmonary artery shunts included modified Blalock-Taussig shunts and endto-side ( Mee ) shunts. Right ventricular outflow tract (RVOT) reconstruction included the following procedures: surgical valvotomy with or without concomitant transannular patching, transannular patch placement, or interposition of a conduit between the right ventricle and the pulmonary artery. Two patients late in the series had radiofrequencyassisted valvotomy and balloon dilation. Initial procedures were performed in 36 patients whose angiograms were unavailable for blinded angiographic review, including systemic-pulmonary artery shunt in 20, primary complete repair in 14, and RVOT reconstruction in 2 patients. NON-MAPCA PATIENTS (n 118). A flowchart of events in patients according to diagnostic group is shown in (Fig. 3). Four patients without MAPCAs, but with other severe non-cardiac anomalies, had no operative intervention. Palliation was performed in 83 and primary complete repair, defined as VSD closure and RVOT reconstruction, occurred in 31 patients. MAPCA PATIENTS (n 53). Eighteen patients with MAPCAs had no operative intervention. The MAPCA patients were more likely to have non-operative management (odds ratio [OR], 14.7; 95% confidence interval [CI], 4.6 to 46.2; p 0.001) Palliation was performed in 23 patients, including RVOT reconstruction in 13 and systemic-pulmonary artery shunt in 10 patients. Procedures directed at MAPCAs concomitant with RVOT reconstruction included complete unifocalization in 5 and partial unifocalization and ligation in 1 patient each. Systemic-pulmonary artery shunts occurred simultaneously with partial unifocalization in 7 patients. Singlestage complete repair, defined as VSD closure, RVOT reconstruction, and single-stage complete unifocalization, occurred in 12 patients. Evolution of initial surgical management over time. Primary complete repair (n 57) was strongly associated with more recent era of operation for all patients regardless of pulmonary arterial anatomy, with 67% (n 38) of initial repairs occurring in era 3 (1995 to 2004), compared with only 32% (n 18) in era 2 (1985 to 1994), and only 2% Figure 3. Events in the 171 patients who underwent blinded angiographic review. Patients were classified into two groups, those with major aortopulmonary collateral arteries (n 53), and those without major aortopulmonary collateral arteries (MAPCAs) (n 118).

5 1452 Amark et al. JACC Vol. 47, No. 7, 2006 Pulmonary Atresia with VSD April 4, 2006: Figure 4. Proportion of patients reaching definitive repair stratified by era. The percentage of patients undergoing primary complete repair (open bars) increased significantly with increasing era, reflecting an important change in the treatment paradigm for children with pulmonary atresia associated with ventricular septal defect. The number of patients reaching repair after prior palliation (solid bars) also predictably increased with longer duration of follow-up. **p (n 1) in era 1 (1975 to 1984) (p ) (Fig. 4). In the MAPCA group, 83% (n 10) of complete primary repairs occurred era 3, compared with only 17% (n 2) in era 2, and none in era 1 (p ). Similarly, in the non- MAPCA group, 97% (n 30) of initial repairs occurred in era 2 and 3, compared with 3% (n 1) in era 1 (p ). Initial catheter interventions. Initial procedures occurred in 23 patients before repair, including balloon dilatation of branch pulmonary arteries stent placement in 12, collateral coiling in 7, and pulmonary valve perforation in 4 patients. Overall mortality. Overall time-related survival from initial operation was 71% at 10 years (Fig. 5). Mortality rate after initial operation was highest during the first year after operation and tapered thereafter. Incremental risk factors for time-related death after operation were sought and are listed in Table 3. Thirty deaths (25%) occurred in patients without MAPCAs, and 21 occurred (40%) in the MAPCA group (p 0.06). Achievement of definitive repair. Complete repair occurred in 139 patients at a median age of 2 years (range, 0 to 15 years). Primary repair without prior palliation occurred in 57 patients. Staged repair was accomplished in 82 patients, 63 in the non-mapca group, 9 in the MAPCA group, and 10 in patients without angiographic review. Competing risks analysis for the 128 patients who underwent initial palliation predicted that at 10 years after palliation, 68% had achieved complete repair, 22% had died without complete repair, and 10% remained alive without repair (Fig. 6). Factors increasing transition rates to complete repair in the 185 who underwent initial reparative operation included later birth cohort and more bronchopulmonary segments supplied by the true pulmonary arteries (Table 3). Decreased transition rates to complete repair and increased pre-repair attrition are evident in patients with MAPCAs, as shown in Figure 7. Outcomes after complete repair. REOPERATIONS. A total of 38 children underwent 47 reoperations after complete intracardiac repair (Table 4). For the 139 patients who underwent complete repair, competing risks analysis predicted that at 5 years after complete repair, 60% remained alive without subsequent operation, 28% had a second operation, and 12% had died without reoperation. Incremental risk factors for reoperation after complete intracardiac repair included being in the MAPCA group, older age at initial palliation, and a greater number of collateral segments (Table 3). CATHETER-BASED REINTERVENTIONS. After complete intracardiac repair, 104 percutaneous interventions occurred in 56 patients at a median age of 1.1 years (range, 0 to 13 years) from repair, including balloon dilatation of branch pulmonary arteries stent placement in 75, balloon dilation stent placement of existing RVOT conduit in 22, and collateral coiling in 7 patients. Percutaneous interventions were more prevalent in the MAPCA group (25%) than in the non- MAPCA group (17%), and at a decreased interval from complete repair (1 year vs. 4 years, p 0.003). Competing risks analysis predicted that at 3 years after complete repair, 35% underwent catheter-based reintervention, 6% had died without reintervention, and 59% remained alive without reintervention. Risk factors for reintervention included use of a homograft for RVOT reconstruction, older age at complete repair, and single-stage complete repair in % Freedom from Death Overall Survival 1 year 83% 5 years 74% 10 years 71% No at risk: Years After Initial Operation Figure 5. Overall survival from initial operation in 185 children with pulmonary atresia associated with ventricular septal defect. There were 47 deaths after initial operation. The hazard function for death after initial operation was characterized by a steep early phase accounting for 14 events, followed by a more gradual later phase accounting for 33 events. Solid lines represent parametric point estimates enclosed by 70% confidence limits; circles with error bars represent nonparametric estimates, and numbers at bottom represent the number of patients followed up at that point.

6 JACC Vol. 47, No. 7, 2006 April 4, 2006: Amark et al. Pulmonary Atresia with VSD 1453 Table 3. Incremental Risk Factors for Time-Related Transition to End States After Initial Operation Variable Parameter Estimate ( SE) p Reliability* (%) For death after initial operation in 185 patients Younger age at repair (per yr) Initial systemic-pa shunt Earlier birth cohort (per yr) Fewer segments supplied by native PAs Fewer segments with a dual supply For survival to complete repair after palliation in 128 patients Later birth cohort (per yr) More segments supplied by native PAs For reoperation after complete repair in 139 patients MAPCA group More segments supplied by collaterals Older age at palliation (per yr) For reintervention after complete repair in 139 patients RVOT reconstruction with homograft Earlier age at repair (per yr) Single-stage complete repair of MAPCAs Interaction term between age at repair and complete repair of MAPCAs *Percent (%) refers to the reliability determined by bootstrap validation (variable resampling) method. After square transformation. After inverse transformation. After logarithmic transformation. MAPCA major aortopulmonary collateral artery; PA pulmonary artery; RVOT right ventricular outflow track. MAPCA patients (Table 3). A significant interaction existed, however, between complete repair in the MAPCA group and age at repair, showing that earlier single-stage repair increased the risk of subsequent interventions (Fig. 8). Follow-up data. Clinical follow-up from first admission was obtained in 216 patients at a median interval of 3.8 years. Mean oxygen saturation (%) at follow-up was higher in patients who underwent primary complete repair (96 3) versus those who had staged palliation (90 12, p 0.001). Follow-up angiograms were obtained in 98 survivors Figure 6. Competing risks depiction of events after initial palliation in 128 children who underwent initial palliation, either right ventricular outflow tract (RVOT) reconstruction (n 23) or initial systemic-pulmonary artery shunt placement (n 105). Competing risks analysis predicted that at 10 years after palliation, 68% had achieved complete repair, 22% had died without complete repair, and 10% remained alive without complete repair. Solid lines represent parametric point estimates, dashed lines enclose 70% confidence limits, circles with error bars represent nonparametric estimates, numbers in parentheses indicate the estimated proportion of patients in each state at 10 years from palliation. (62%) at a median interval of 6 years from initial admission (Table 2). Mean right ventricular/systemic pressure (%) was Asymptomatic clinical status was associated with primary complete repair (OR, 3.6; 95% CI, 1.2 to 10.9; p 0.02), achievement of complete repair at any time (OR, 13.0; 95% CI, 3.7 to 47; p 0.001), and the absence of MAPCAs (OR, 0.3; 95% CI, 0.1 to 0.8; p 0.01) on multivariable analysis after adjustment for follow-up duration and operation era. At 6 years after initial operation, patients who underwent systemic-pulmonary artery shunts had less pulmonary arterial growth (median Nakata 74; range, 133 to 430) than those undergoing other initial operations after correction for initial anatomy (median Nakata 102; range, 205 to 520), p DISCUSSION Mortality. The 10-year survival in our series of 71% is higher than in other historical series (3,17,18). Incremental risk factors for death after initial operation in this study included earlier birth cohort, systemic-pulmonary artery shunt placement, increasing number of lung segments supplied by MAPCAs, and younger age at complete repair. Improved survival for those undergoing operation in a later era is multifactorial. The prevalence of primary complete repair increased dramatically in the later eras, as did the proportion of patients reaching definitive repair. Similarly, the use of systemic-pulmonary artery shunts as the first stage decreased with later birth cohort in favor of RVOT reconstruction. Patients undergoing systemic-pulmonary artery shunts had increased mortality independent of other factors, potentially related to decreased pulmonary parenchymal recruitment

7 1454 Amark et al. JACC Vol. 47, No. 7, 2006 Pulmonary Atresia with VSD April 4, 2006: Figure 7. Competing risks diagrams depicting the estimated prevalence of three mutually exclusive end states in 187 patients after initial operation: achievement of complete repair, death without repair, and remaining alive without repair. (A) Decreased rates of transition to complete repair and a higher prevalence of death are seen in a patient with only three bronchopulmonary segments supplied by the true pulmonary arteries and a large number of major aortopulmonary collateral arteries (MAPCAs). (B) Patients with all 18 bronchopulmonary segments supplied by the true pulmonary arteries via the ductus arteriosus, and therefore no MAPCAs, have increased transition rates to complete repair and lower pre-repair attrition. with this technique (5,19,20). Decreased pulmonary arterial growth rate, measured by Nakata index, in patients with shunts supports this contention. An earlier report by Freedom et al. (10) from our institution describing our initial experience with RVOT reconstruction showed no conclusive benefit with respect to symmetric pulmonary arterial growth, but included only 15 patients, only 5 of whom had angiographic follow-up. The potential disadvantage of systemic-pulmonary artery shunts has been suggested by the results from other series (5,19,20). Other factors not evaluated in this study likely also contributed to improved results over time. Variables relating to the morphology of the pulmonary arterial circulation are well-known risk factors for death after repair, but their influence on other important outcomes, including the achievement of complete repair, reoperations, percutaneous reintervention, and long-term clinical status, has not been previously described (7,21 24). We have fully characterized the bronchopulmonary anatomy in the largest series of patients with PAVSD, and have shown that increased collateral supply adversely impacts end-state achievement independent of choice of initial management. This risk factor is likely a surrogate for elevated pulmonary arterial or vascular resistance, which is inversely related to the number of pulmonary arterial segments connected to an ipsilateral central pulmonary artery (25). The importance of evaluating Table 4. Reoperations After Complete Intracardiac Repair Operation n Conduit replacement 33 Pulmonary valve insertion 6 Branch pulmonary arterioplasty 2 Unifocalization 2 Pacemaker insertion 2 Resection of RVOT aneurysm 1 Ligation of MAPCAs 1 MAPCA major aortopulmonary collateral artery; n number of procedures; RVOT right ventricular outflow tract.

8 JACC Vol. 47, No. 7, 2006 April 4, 2006: Amark et al. Pulmonary Atresia with VSD 1455 Figure 8. Risk-adjusted freedom from reintervention after repair for varying age at complete repair stratified according to major aortopulmonary collateral artery (MAPCA) group. The multivariable equation from the competing risk model was solved twice (for patients with MAPCAs and for those without), each time entering mean values for other predictors. Decreased rates of catheter-based reintervention are illustrated for MAPCA patients when single-stage repair is performed at a later age. Solid lines represent parametric determination of freedom from reintervention for given age at repair; dashed lines enclose 70% confidence intervals. pulmonary arterial supply not only before initial treatment but also throughout the patient s clinical course is highlighted by the profound influence of bronchopulmonary arterial anatomy on outcomes (22). We were surprised that given the known advantages of early surgical intervention and the improved long-term clinical status in repaired cases, earlier age at repair was a risk factor for death after operation. One potential explanation is that median age at repair in our series is lower than in many other reports despite the large preponderance of staged patients (3,5,8,17,18,22,23,26). Thus, the finding of early repair as a risk factor may reflect the fact that the designation early is potentially arbitrary and depends on one s perspective. More likely, however, is that commitment to early definitive repair is a long-term investment requiring some initial cost. This is analogous to the evolution in management favoring arterial switch operation over atrial switch operation, in which the historically slightly higher mortality of a new operation was mitigated by the potential long-term functional benefit (27). Patients who underwent repair and survived had greater improvement in long-term clinical status, were less cyanosed, and had more favorable pulmonary arterial characteristics at follow-up compared with those who remained palliated or did not undergo surgery. Achievement of complete repair. Achievement of complete repair occurred in 70% of patients in our study, which was similar to the rates achieved in other reports (3,17,18,22). Later year of operation was strongly associated with definitive repair because of the increased prevalence of primary repair and because enough time elapsed for previously staged patients to reach this state. Patients who had undergone repair had acceptable mean right ventricular/left ventricular pressures at late follow-up and significant growth of the pulmonary arterial vascular bed. Reoperation after definitive repair occurred frequently and was associated with increased number of MAPCAs and later age at initial palliation. Delayed palliation increases the duration for which the collateral vessels are exposed to systemic arterial pressure and may predispose to the development of pulmonary vascular obstructive disease in supplied lung segments, especially in the absence of important MAPCA stenoses (8). Encouraging, however, is that despite the high incidence of post-repair reoperation, the majority of non-mapca survivors were asymptomatic and clinically well. Catheter-based reintervention. The MAPCA patients undergoing single-stage complete repair had an increased risk of reintervention, and this effect was more pronounced when repair was performed at an earlier age. High reintervention risk in this group may contribute to our finding that completely repaired MAPCA patients had a worse clinical status than completely repaired non-mapca patients. Additionally, catheter-based intervention accounted for six deaths in our series. Risk rates of reintervention in the MAPCA group approximated those in the non-mapca group after 8 months of age, suggesting that delaying single-stage repair outside of the neonatal period may afford some benefit. Although it can be argued that sequential reinterventions in patients with MAPCAs are mandated as part of the treatment algorithm, and therefore may not represent adverse events per se, clear evidence supporting this notion is currently lacking. CONCLUSIONS We have shown important improvement in outcomes over time that are associated with a shift in treatment paradigm emphasizing primary repair for those with simple PAVSD and an individualized approach for those with MAPCAs tailored to the adequacy of the pulmonary arterial bed. Our results confirm that RVOT reconstruction as the initial procedure is preferable to systemic-pulmonary artery shunt placement for patients in whom primary repair is not feasible, and that surgical decisions should be tailored to well-defined bronchopulmonary anatomy. Reprint requests and correspondence: Dr. Brian W. McCrindle, The Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, Canada M5G 1X8. brian.mccrindle@sickkids.ca. REFERENCES 1. Rodefeld MD, Reddy VM, Thompson LD, et al. Surgical creation of aortopulmonary window in selected patients with pulmonary atresia with poorly developed aortopulmonary collaterals and hypoplastic pulmonary arteries. J Thorac Cardiovasc Surg 2002;123: Metras D, Chetaille P, Kreitman B, Fraisse A, Ghez O, Riberi A. Pulmonary atresia with ventricular septal defect, extremely hypoplastic

9 1456 Amark et al. JACC Vol. 47, No. 7, 2006 Pulmonary Atresia with VSD April 4, 2006: pulmonary arteries, major aorto-pulmonary collaterals. Eur J Cardiothorac Surg 2001;20: Bull K, Somerville J, Ty E, Spiegelhalter D. Presentation and attrition in complex pulmonary atresia. J Am Coll Cardiol 1995;25: Murthy KS, Rao SG, Naik SK, Coelho R, Krishnan US, Cherian KM. Evolving surgical management for ventricular septal defect, pulmonary atresia, and major aortopulmonary collateral arteries. Ann Thorac Surg 1999;67: Carotti A, Albanese SB, Minniti G, Guccione P, DiDonato RM. Increasing experience with integrated approach to pulmonary atresia with ventricular septal defect and major aortopulmonary collaterals. Eur J Cardiothorac Surg 2003;23: Reddy VM, Petrossian E, McElhinney DB, Moore P, Teitl DF, Hanley FL. One-stage complete unifocalization in infants: when should the ventricular septal defect be closed? J Thorac Cardiovasc Surg 1997;113: Reddy VM, McElhinney DB, Amin Z, et al. Early and intermediate outcomes after repair of pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries: experience with 85 patients. Circulation 2000;101: Tchervenkov CI, Salasidis G, Cecere R, et al. One-stage midline unifocalization and complete repair in infancy versus multiple-stage unifocalization followed by repair for complex heart disease with major aortopulmonary collaterals. J Thorac Cardiovasc Surg 1997;114: Somerville J, Saravalli O, Ross D. Complex pulmonary atresia with congenital systemic collaterals. Classification and management. Arch Mal Coeur Vaiss 1978;71: Jefferson K, Rees S, Somerville J. Systemic arterial supply to the lungs in pulmonary atresia and its relation to pulmonary artery development. Br Heart J 1972;34: Blackstone EH, Naftel DC, Turner ME Jr. The decomposition of time-varying hazard into phases, each incorporating a separate stream of concomitant information. J Am Stat Assoc 1986;81: McGriffin DC, Naftel DC, Kirklin JK, et al., and the Pediatric Heart Transplant Study Group. Predicting outcome after listing for heart transplantation in children: a comparison of Kaplan-Meier and parametric competing risk analysis. Pediatric Heart Transplant Study Group. J Heart Lung Transplant 1997;16: Prentice RL, Kalbfleisch JD, Peterson AV Jr., Flournoy N, Farewell VT, Breslow NE. The analysis of failure times in the presence of competing risks. Biometrics 1978;34: The Cleveland Clinic Heart and Vascular Institute. Hazard Function Technology. Available at: hazard. Accessed October 1, Cox DR. Regression models and life tables. J R Stat Soc B 1972;34: Blackstone EH, Rice TW. Clinical-pathologic conference: choice and use of statistical methods for the clinical study Superficial adenocarcinoma of the esophagus. J Thorac Cardiovasc Surg 2001;122: Dinarevic S, Redington A, Rigby M, Shinebourne EA. Outcome of pulmonary atresia and ventricular septal defect during infancy. Pediatr Cardiol 1995;16: Millikan JS, Puga FJ, Danielson GK, Schlaff HV, Julsrud PR, Mair DD. Staged surgical repair of pulmonary atresia, ventricular septal defect, and hypoplastic, confluent pulmonary arteries. J Thorac Cardiovasc Surg 1986;91: Gill CC, Moodie DS, McGoon DC. Staged surgical management of pulmonary atresia with diminutive pulmonary arteries. J Thorac Cardiovasc Surg 1977;73: Piehler JM, Danielson GK, McGoon DC, Wallace RB, Fulton RE, Mair DD. Management of pulmonary atresia with ventricular septal defect and hypoplastic pulmonary arteries by right ventricular outflow construction. J Thorac Cardiovasc Surg 1980;80: Freedom RM, Pongiglione G, Williams WG, Trusler GA, Rowe RD. Palliative right ventricular outflow tract construction for patients with pulmonary atresia, ventricular septal defect, and hypoplastic pulmonary arteries. J Thorac Cardiovasc Surg 1983;86: DeGiovanni JV. Timing, frequency, and results of catheter intervention following recruitment of major aortopulmonary collaterals in patients with pulmonary atresia and ventricular septal defect. J Interv Cardiol 2004;17: Gupta A, Odim J, Levi D, Chang RK, Laks H. Staged repair of pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries: experience with 104 patients. J Thorac Cardiovasc Surg 2003;126: Hirsch JC, Mosca RS, Bove EL. Complete repair of tetralogy of Fallot in the neonate: results in the modern era. Ann Surg 2000;232: Shimazaki Y, Tokuan Y, Lio M, et al. Pulmonary artery pressure and resistance late after repair of tetralogy of Fallot with pulmonary atresia. J Thorac Cardiovasc Surg 1990;100: Yagihara T, Yamamoto F, Nishigaki K, et al. Unifocalization for pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries. J Thorac Cardiovasc Surg 1996;112: Culbert EL, Ashburn DA, Cullen-Dean G, et al. Quality of life of children after transposition of the great arteries. Circulation 2003;108: